Concepedia

Benjamin J. Whalley

BJ

Statistics

Publications

53

Citations

3.6K

H-Index

32

Active since

2003

Affiliations

University of Reading(Current)

GW Pharmaceuticals (United Kingdom)

University College London

Medway School of Pharmacy

University of London

Benjamin J. Whalley is an author at University of Reading specializing in neuroscience, neuropharmacology, and medicine.

Publications per year

2003–2023

53

Publications

53

Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability

Fabio Arturo Iannotti, Charlotte L. Hill, Antonio Leo et al. · ACS Chemical Neuroscience · 2014 · 404 citations

, , +15

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

Nicholas A. Jones, Andrew J. Hill, Imogen Smith et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 343 citations · Full text

, , +17

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

Nicholas A. Jones, Sarah Glyn, Satoshi Akiyama et al. · Seizure · 2012 · 242 citations · Full text

, , +10

The proposed mechanisms of action of CBD in epilepsy

Royston A. Gray, Benjamin J. Whalley · Epileptic Disorders · 2020 · 206 citations · Full text

, , +13

Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a <scp>CB<sub>1</sub></scp> receptor‐independent mechanism

Thomas D.M. Hill, M. G. Cascio, Barbara Romano et al. · British Journal of Pharmacology · 2013 · 188 citations · Full text

, , +13

1–5 of 53